Breast Cancer Clinical Trials in Chicago

Showing 141-160 of 556 trials

Physical Activity Promotion for Breast and Endometrial Cancer Survivors

NCT04262180

Many breast and endometrial cancer survivors do not get enough physical activity. Technology-based interventions can be inexpensive and easy to scale up, however they are not effective for all women. The purpose of this study is test an adaptive physical activity intervention approach that reserves the most resources and support for women who do not fare well with a lower-cost, minimal intervention. The results from this trial will inform the development of scalable physical activity interventions for breast and endometrial cancer survivors.

Physical ActivityBreast Cancer SurvivorsEndometrial Cancer Survivors

University of Wisconsin, Madison323 participantsStarted Nov 2020

Chicago, Illinois, United States • Madison, Wisconsin, United States

RECRUITINGPhase 22.2 miles

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

NCT06533826

The purpose of this study is to test the safety and effectiveness of the sequence of two investigational drugs (trastuzumab deruxtecan followed by datopotamab deruxtecan, or datopotamab deruxtecan followed by trastuzumab deruxtecan) to learn whether the treatment works in treating HER2-negative (HER2-low or HER2-0) metastatic breast cancer. The names of the study drugs involved in this study are: * Datopotamab deruxtecan (a type of antibody drug conjugate) * Trastuzumab deruxtecan (a type of antibody drug conjugate)

Breast CancerHER2-low Breast CancerMetastatic Breast Cancer+1 more

Ana C Garrido-Castro, MD357 participantsStarted Oct 2024

Birmingham, Alabama, United States • San Francisco, California, United States • New Haven, Connecticut, United States +8 more locations

Physical Activity Promotion for Breast and Endometrial Cancer Survivors

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Breast Cancer Trials in Other Cities

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study)

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Assessing the Time Demands of Cancer

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Other Conditions in Chicago